Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse

IntroductionTo sustain the achievement of kala-azar elimination program (KEP), early detection and treatment of the visceral leishmaniasis (VL) cases and associated modalities such as treatment failure (TF), relapse VL (RVL), and Post-kala-azar dermal leishmaniasis (PKDL) is the cornerstone. A predi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dinesh Mondal, Prakash Ghosh, Rajashree Chowdhury, Christine Halleux, Jose A. Ruiz-Postigo, Abdul Alim, Faria Hossain, Md Anik Ashfaq Khan, Rupen Nath, Malcolm S. Duthie, Axel Kroeger, Greg Matlashewski, Daniel Argaw, Piero Olliaro
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019-10-01
Edice:Frontiers in Microbiology
Témata:
visceral leishmaniasis (VL)
treatment failure (TF)
relapse VL (RVL)
Post-kala-azar dermal leishmaniasis (PKDL)
rK39 antibody
ELISA
On-line přístup:https://www.frontiersin.org/article/10.3389/fmicb.2019.02268/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky